日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Brazilian guidelines for the treatment of outpatients with suspected or confirmed COVID-19. A joint guideline of the Brazilian Association of Emergency Medicine (ABRAMEDE), Brazilian Medical Association (AMB), Brazilian Society of Angiology and Vascular Surgery (SBACV), Brazilian Society of Geriatrics and Gerontology (SBGG), Brazilian Society of Infectious Diseases (SBI), Brazilian Society of Family and Community Medicine (SBFMC), and Brazilian Thoracic Society (SBPT)

巴西疑似或确诊 COVID-19 门诊患者治疗指南。该指南由巴西急诊医学协会 (ABRAMEDE)、巴西医学协会 (AMB)、巴西血管外科协会 (SBACV)、巴西老年医学与老年病学会 (SBGG)、巴西传染病学会 (SBI)、巴西家庭与社区医学协会 (SBFMC) 和巴西胸科协会 (SBPT) 联合制定。

Falavigna, Maicon; Belli, Karlyse Claudino; Barbosa, Alexandre Naime; Zavascki, Alexandre Prehn; Nastri, Ana Catharina de Seixas Santos; Santana, Christiane Machado; Stein, Cinara; Gräf, Débora Dalmas; Cadegiani, Flavio Adsuara; Guimarães, Hélio Penna; Monteiro, José Tadeu; Ferreira, Juliana Carvalho; de Azevedo, Luciano Cesar Pontes; Magri, Marcelo Mihailenko Chaves; Sobreira, Marcone Lima; Dias, Maria Beatriz Gandra de Souza; de Oliveira, Maura Salaroli; Corradi, Mirian de Freitas Dal Ben; Rosa, Regis; Heinzelmann, Ricardo Souza; da Silva, Rosemeri Maurici; Junior, Rubens Belfort; Cimerman, Sergio; Colpani, Verônica; Veiga, Viviane Cordeiro; de Carvalho, Carlos Roberto Ribeiro

"MATH+" Multi-Modal Hospital Treatment Protocol for COVID-19 Infection: Clinical and Scientific Rationale

“MATH+”多模式医院治疗方案治疗COVID-19感染:临床和科学原理

Kory, Pierre; Meduri, Ginfranco Umberto; Iglesias, Jose; Varon, Joseph; Cadegiani, Flavio Adsuara; Marik, Paul E

Ivermectin Prophylaxis Used for COVID-19: A Citywide, Prospective, Observational Study of 223,128 Subjects Using Propensity Score Matching

伊维菌素预防COVID-19:一项采用倾向评分匹配法对223,128名受试者进行的城市前瞻性观察研究

Kerr, Lucy; Cadegiani, Flavio A; Baldi, Fernando; Lobo, Raysildo B; Assagra, Washington Luiz O; Proença, Fernando Carlos; Kory, Pierre; Hibberd, Jennifer A; Chamie-Quintero, Juan J

Correction: Ivermectin Prophylaxis Used for COVID-19: A Citywide, Prospective, Observational Study of 223,128 Subjects Using Propensity Score Matching

更正:伊维菌素预防 COVID-19:一项采用倾向评分匹配法对 223,128 名受试者进行的城市范围前瞻性观察研究

Kerr, Lucy; Cadegiani, Flavio A; Baldi, Fernando; Lobo, Raysildo B; Assagra, Washington Luiz O; Proença, Fernando Carlos; Kory, Pierre; Hibberd, Jennifer A; Chamie-Quintero, Juan J

Regular Use of Ivermectin as Prophylaxis for COVID-19 Led Up to a 92% Reduction in COVID-19 Mortality Rate in a Dose-Response Manner: Results of a Prospective Observational Study of a Strictly Controlled Population of 88,012 Subjects

一项对88012名严格控制人群进行的前瞻性观察研究显示,规律使用伊维菌素预防COVID-19可使COVID-19死亡率降低高达92%,且呈剂量反应关系。

Kerr, Lucy; Baldi, Fernando; Lobo, Raysildo; Assagra, Washington Luiz; Proença, Fernando Carlos; Chamie, Juan J; Hibberd, Jennifer A; Kory, Pierre; Cadegiani, Flavio A

Catecholamines Are the Key Trigger of COVID-19 mRNA Vaccine-Induced Myocarditis: A Compelling Hypothesis Supported by Epidemiological, Anatomopathological, Molecular, and Physiological Findings

儿茶酚胺是新冠病毒mRNA疫苗诱发心肌炎的关键触发因素:流行病学、解剖病理学、分子生物学和生理学研究结果支持的有力假设

Cadegiani, Flavio A

Androgen receptor genetic variant predicts COVID-19 disease severity: a prospective longitudinal study of hospitalized COVID-19 male patients

雄激素受体基因变异可预测 COVID-19 疾病严重程度:一项针对住院 COVID-19 男性患者的前瞻性纵向研究

McCoy, J; Wambier, C G; Herrera, S; Vaño-Galván, S; Gioia, F; Comeche, B; Ron, R; Serrano-Villar, S; Iwasiow, R M; Tayeb, M A; Cadegiani, F A; Mesinkovska, N A; Shapiro, J; Sinclair, R; Goren, A

Anti-androgens may protect against severe COVID-19 outcomes: results from a prospective cohort study of 77 hospitalized men

抗雄激素可能有助于预防新冠肺炎重症:一项针对 77 名住院男性患者的前瞻性队列研究结果显示

Goren, A; Wambier, C G; Herrera, S; McCoy, J; Vaño-Galván, S; Gioia, F; Comeche, B; Ron, R; Serrano-Villar, S; Ramos, P M; Cadegiani, F A; Kovacevic, M; Tosti, A; Shapiro, J; Sinclair, R

Early COVID-19 therapy with azithromycin plus nitazoxanide, ivermectin or hydroxychloroquine in outpatient settings significantly improved COVID-19 outcomes compared to known outcomes in untreated patients

在门诊环境中,早期使用阿奇霉素联合硝唑尼特、伊维菌素或羟氯喹治疗新冠肺炎,与未治疗患者的已知预后相比,显著改善了新冠肺炎的预后。

Cadegiani, F A; Goren, A; Wambier, C G; McCoy, J

Editorial: New Perspectives on the Endocrinology of Physical Activity and Sport

社论:体育活动和运动内分泌学的新视角

Ackerman, Kathryn E; Collomp, Katia; Kater, Claudio E; Cadegiani, Flavio Adsuara